← Back to Search

Procedure

Miniaturized Percutaneous Nephrolithotomy for Kidney Stones

N/A

Recruiting

Led By Sriharan Sivalingam

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: ≥ 18 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3-7 days

Awards & highlights

Study Summary

This trial compares two methods for kidney stone treatment, both of which have proven safe and effective.

Who is the study for?

This trial is for adults over 18 with kidney stones sized between 10-25 mm, who can consent and meet study requirements. It's open to all ethnicities and genders. Those with a nephrostomy tube or ureteral stent already in place may join. People on blood thinners, with coagulation disorders, congenital kidney anomalies, previous kidney surgeries, or needing multiple access tracts are excluded.Check my eligibility

What is being tested?

The study compares two surgical methods for removing kidney stones: one using a vacuum-assisted sheath and the other using a conventional sheath during mini-PCNL (a minimally invasive surgery). The goal is to determine which method is more effective for patients like you.See study design

What are the potential side effects?

Potential side effects from both procedures include bleeding, infection risk at the site of surgery, pain where the stone was removed, possible damage to surrounding tissues or organs during the procedure, and complications related to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3-7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3-7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Aim 1: Stone free rate

Aim 2: Intraoperative variables

Aim 3: Post-operative Outcomes and Complications

Trial Design

2Treatment groups

Active Control

Group I: passive suction via conventional sheathActive Control2 Interventions

Group II: vacuum-assisted sheathActive Control1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

The Cleveland ClinicLead Sponsor

1,030 Previous Clinical Trials

1,365,468 Total Patients Enrolled

5 Trials studying Kidney Stones

3,640 Patients Enrolled for Kidney Stones

Sriharan SivalingamPrincipal InvestigatorPrincipal Investigator

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for participants in this research?

"This clinical experiment is accepting participants, as evidenced on the website of clinicaltrials.gov. It was initially advertised on August 29th 2023 and recently updated November 7th 2023."

Answered by AI

How extensive is the participation in this experiment?

"Affirmative. According to clinicaltrials.gov, this trial is still recruiting patients and was initially posted on August 29th 2023. It has since been modified as of November 7th 2023. The research endeavour requires 90 participants from a single site for recruitment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis

2023. "Randomized Controlled Trial of Miniaturized Percutaneous Nephrolithotomy With Vacuum-Assisted Access Sheaths Versus Conventional Sheaths for Treatment of Nephrolithiasis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05993546.

All > Kidney Stone